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‘The rise of cancer in less affluent countries is an 
impending disaster’
Dr. Margaret Chan WHO Director-General 2008
Sixty high level policy makers, leaders and health experts 
met this year in August, in Geneva, at the World Cancer 
Summit organized by the International Union Against 
Cancer (UICC), to adopt ambitious targets for cancer care. 
In a World Cancer Declaration 11 targets (see box) are set for 
2020. The Declaration outlines steps that need to be taken to 
achieve success.1,2
About 25 million people in the world live with cancer; it is 
the second leading cause of  death in the world (accounting 
for 14% of  all deaths), and by 2010, it is predicted to become 
the leading cause.  WHO forecasts that by 2030, over 11 
million people will die every year of  cancer;1  72% of  these 
deaths will occur in developing countries. In 2005, for the 
first time, WHO declared the fight against cancer a priority 
and global awareness has gradually been increasing.3 But it 
has still not become part of  the 
political agenda even though 
cancer kills more people than 
tuberculosis, AIDS and malaria 
combined.4 Collingridge writes 
in frustration in the Lancet 
Oncology that this message 
has fallen on deaf  ears for too 
long, especially as many deaths 
are needless and preventable.5 
Vaccination against such 
infections as hepatitis B, and 
human papilloma virus could 
prevent half  a million deaths 
from  liver and cervical cancer. 
Screening programmes are 
improving and becoming 
affordable but need to be freely 
available and accessible at 
primary health level.
Paediatric oncologists met in 
Ponte di Legno in 2004 and stated that  ‘all children in the world 
have a right to full access to essential treatment for acute lymphoblastic 
leukaemia and other cancers and called upon all authorities to recognise 
and support all measures that promote this chance of  cure’6. The 
principle of  ‘distributive justice’ has been used to explain that 
because an illness affects relatively few people in a population 
this does not make it unimportant or unnecessary to provide 
essential treatment for them.7 WHO has now included cancer 
drugs on the ‘essential medicines’ list. 
It is important for cancer care to be adapted to local 
circumstances, culture, understanding and medical facilities. 
Howard et al emphasise the importance of  local adaptation 
of  protocols, training of  staff  in the administration of  drugs, 
a supportive infrastructure and an unbroken supply of  
essential chemotherapy. Treatments are often long (3 years 
for ALL) and in high income countries non-compliance is 
cited as being the most common difficulty. In low income 
countries financial worries are foremost.8 
One of  the targets for 2020 is to provide proper pain control 
for cancer patients and it is heartening to see how palliative 
care teams in Malawi are expanding in number and greatly 
improving pain control. The availability of  oral morphine 
has made a huge difference to patients.  Families and health 
carers, previously demoralized by the inability to help have 
been empowered by the ability to control discomfort and 
pain.
 In this issue of  the MMJ, Mlombe writes about different drug 
regimens for treating Kaposi Sarcoma (KS). It is now, with the 
AIDS epidemic, the first or second most common cancer in 
Malawi in adults and children. HIV related KS is not curable 
but symptoms can be alleviated with chemotherapy and the 
progress of  the disease may be slowed. Antiretroviral drugs 
are the most important (and most easily available) treatment 
option but then there are several combination therapies that 
have been tried and found useful on a case by case basis. 
There is no good comparative study to guide us as to the best 
therapy to offer, bearing in mind that this is palliative care, 
and that chemotherapy can have 
debilitating side effects. It can 
also be a great finance burden to 
the family.
Cancer, and other illnesses such 
as HIV, remind us that as health 
providers we look after those 
who will get better and those 
who die. We must be advocates 
for prevention, supporters of  
all efforts to provide care and 
cure the curable. We need to be 
alert to the patient’s real needs 
and wishes and in those that will 
not be cured there should be a 
gradual transition from active 
to supportive treatment. This 
requires the united efforts and 
commitment of  the family, the 
patient and carers. 
Mary Robinson, former UN 
commissioner for human rights and chairman of  the World 
Cancer summit said. ‘Ultimately it is a question of  human rights 
and above all it is a question of  human dignity’. 
There is, always something we can do.          
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11 points of the World Cancer Declaration 2008
▪ Availability of  cancer- control plans in all countries
▪ Substantial improvement in measurement of  global 
cancer burden
▪ Substantial decrease in tobacco consumption, obesity 
and alcohol intake
▪ Universal vaccination in areas affected  by human 
papilloma virus and hepatitis B
▪ Misconceptions about cancer dispelled
▪ Substantial improvements in early detected 
programmes
▪ Diagnosis and access to cancer treatment, including 
palliative care improved worldwide
▪ Effective pain control universally available
▪ Greatly improved training opportunities in oncology
▪ Substantial decrease in migration of  health workers
▪ Major improvement in cancer survival in all countries
